PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-34.85%
Both yoy net incomes decline, with CRK at -9.82%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
10.84%
D&A growth well above CRK's 4.45%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
28.68%
Well above CRK's 6.10% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
95.11%
Slight usage while CRK is negative at -184.27%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
95.11%
Growth of 95.11% while CRK is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-66.94%
Both negative yoy, with CRK at -196.85%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
2.36%
Some CFO growth while CRK is negative at -34.59%. John Neff would note a short-term liquidity lead over the competitor.
-39.96%
Negative yoy CapEx while CRK is 32.28%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.36%
Growth of 70.36% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-37.33%
We reduce yoy invests while CRK stands at 32.28%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-834.30%
We cut debt repayment yoy while CRK is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-92.96%
Negative yoy issuance while CRK is 10.36%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
68.61%
Buyback growth of 68.61% while CRK is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.